SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-20-006998
Filing Date
2020-05-07
Accepted
2020-05-07 16:54:12
Documents
76
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q xfor-20200331.htm   iXBRL 10-Q 1903437
2 EX-10.1 ex101.htm EX-10.1 16127
3 EX-31.1 ex-311q12020.htm EX-31.1 10939
4 EX-31.2 ex-312q12020.htm EX-31.2 10920
5 EX-32.1 ex-321q12020.htm EX-32.1 9484
11 xfor-20200331_g1.jpg GRAPHIC 70840
  Complete submission text file 0001628280-20-006998.txt   7497196

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xfor-20200331.xsd EX-101.SCH 62168
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT xfor-20200331_cal.xml EX-101.CAL 78453
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT xfor-20200331_def.xml EX-101.DEF 198365
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xfor-20200331_lab.xml EX-101.LAB 631988
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xfor-20200331_pre.xml EX-101.PRE 374211
64 EXTRACTED XBRL INSTANCE DOCUMENT xfor-20200331_htm.xml XML 1158753
Mailing Address 955 MASSACHUSETTS AVENUE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 955 MASSACHUSETTS AVENUE 4TH FLOOR CAMBRIDGE MA 02139 857-529-8300
X4 Pharmaceuticals, Inc (Filer) CIK: 0001501697 (see all company filings)

IRS No.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38295 | Film No.: 20857342
SIC: 2836 Biological Products, (No Diagnostic Substances)